Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.4M Sell
53,250
-2,363
-4% -$508K 0.09% 277
2026
Q1
$12.1M Sell
55,613
-25,600
-32% -$5.68M 0.08% 291
2025
Q4
$18.6M Sell
81,213
-19,750
-20% -$4.5M 0.13% 206
2025
Q3
$23.4M Sell
100,963
-6,700
-6% -$1.36M 0.16% 162
2025
Q2
$20M Sell
107,663
-6,800
-6% -$1.26M 0.14% 188
2025
Q1
$24M Sell
114,463
-5,550
-5% -$1.08M 0.18% 142
2024
Q4
$21.3M Sell
120,013
-18,087
-13% -$3.33M 0.16% 170
2024
Q3
$27.3M Sell
138,100
-1,800
-1% -$336K 0.2% 136
2024
Q2
$24M Buy
139,900
+350
+0.3% +$58K 0.18% 147
2024
Q1
$25.4M Sell
139,550
-2,750
-2% -$474K 0.19% 149
2023
Q4
$22.1M Sell
142,300
-1,200
-0.8% -$175K 0.17% 168
2023
Q3
$21.4M Buy
143,500
+350
+0.2% +$51.4K 0.17% 167
2023
Q2
$19.3M Sell
143,150
-1,050
-0.7% -$154K 0.15% 194
2023
Q1
$23M Buy
144,200
+7,300
+5% +$1.12M 0.17% 165
2022
Q4
$22.1M Sell
136,900
-4,025
-3% -$617K 0.17% 166
2022
Q3
$18.9M Buy
140,925
+1,225
+0.9% +$176K 0.16% 180
2022
Q2
$21.4M Buy
139,700
+10,360
+8% +$1.58M 0.16% 173
2022
Q1
$21M Sell
129,340
-12,550
-9% -$1.82M 0.14% 208
2021
Q4
$19.2M Buy
141,890
+11,125
+9% +$1.31M 0.12% 218
2021
Q3
$14.1M Buy
130,765
+15,175
+13% +$1.73M 0.09% 267
2021
Q2
$13M Buy
115,590
+2,200
+2% +$248K 0.08% 309
2021
Q1
$12.3M Buy
113,390
+30,894
+37% +$3.3M 0.08% 305
2020
Q4
$8.84M Buy
82,496
+16,900
+26% +$1.62M 0.06% 351
2020
Q3
$5.75M Sell
65,596
-8,000
-11% -$753K 0.04% 408
2020
Q2
$7.23M Buy
73,596
+65,296
+787% +$5.75M 0.06% 363
2020
Q1
$632K Buy
8,300
+4,300
+108% +$366K 0.01% 843
2019
Q4
$354K Hold
4,000
﹤0.01% 976
2019
Q3
$303K Sell
4,000
-2,000
-33% -$137K ﹤0.01% 1013
2019
Q2
$436K Hold
6,000
﹤0.01% 1000
2019
Q1
$484K Hold
6,000
﹤0.01% 975
2018
Q4
$553K Sell
6,000
-2,000
-25% -$176K ﹤0.01% 954
2018
Q3
$757K Sell
8,000
-84,200
-91% -$7.98M ﹤0.01% 954
2018
Q2
$8.54M Sell
92,200
-3,500
-4% -$342K 0.05% 414
2018
Q1
$9.06M Sell
95,700
-2,000
-2% -$220K 0.05% 397
2017
Q4
$9.45M Hold
97,700
0.05% 400
2017
Q3
$8.68M Hold
97,700
0.05% 423
2017
Q2
$7.08M Buy
97,700
+1,500
+2% +$101K 0.04% 471
2017
Q1
$6.27M Sell
96,200
-11,000
-10% -$692K 0.04% 506
2016
Q4
$6.71M Sell
107,200
-59,000
-35% -$3.6M 0.04% 474
2016
Q3
$10.5M Sell
166,200
-3,200
-2% -$207K 0.06% 371
2016
Q2
$10.5M Sell
169,400
-10,056
-6% -$613K 0.06% 368
2016
Q1
$10.3M Sell
179,456
-1,600
-0.9% -$89.2K 0.06% 378
2015
Q4
$10.7M Buy
181,056
+3,500
+2% +$202K 0.06% 376
2015
Q3
$9.66M Sell
177,556
-18,735
-10% -$1.22M 0.06% 405
2015
Q2
$13.2M Buy
196,291
+28,991
+17% +$1.89M 0.07% 367
2015
Q1
$9.79M Buy
167,300
+22,300
+15% +$1.35M 0.05% 438
2014
Q4
$9.49M Buy
145,000
+75,000
+107% +$4.73M 0.05% 457
2014
Q3
$4.04M Hold
70,000
0.02% 641
2014
Q2
$3.95M Hold
70,000
0.02% 650
2014
Q1
$3.6M Hold
70,000
0.02% 652
2013
Q4
$3.7M Hold
70,000
0.02% 637
2013
Q3
$3.13M Hold
70,000
0.02% 656
2013
Q2
$2.89M Buy
+70,000
New +$3.06M 0.02% 647

Other funds holding ABBV

Gabelli Funds's ABBV Position: Q2 2026 in Review

Gabelli Funds reduced its AbbVie (ABBV) stake by 4.2% in Q2 2026, selling an estimated $508K and leaving 53,250 shares worth $13.4M. The position accounts for 0.09% of the portfolio, ranked #277.

Gabelli Funds first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $27.3M in Q3 2024. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Gabelli Funds held 53,250 shares of AbbVie worth $13.4M as of Q2 2026.
  • Gabelli Funds sold 2,363 AbbVie shares in Q2 2026, an estimated $508K.
  • AbbVie made up 0.09% of Gabelli Funds's portfolio in Q2 2026, its #277 holding.
  • Gabelli Funds first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Gabelli Funds's AbbVie position peaked at $27.3M in Q3 2024.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.